Work

Genomic predictors of response to doxorubicin versus docetaxel in primary breast cancer

Year: 2011

Type: article

Source: Breast Cancer Research and Treatment

DOI: 10.1007/s10549-011-1461-y

Authors: M. Martin, A. Romero, M. C. U. Cheang, J. A. López García-Asenjo, J. A. García-Saenz, B. Oliva, J. M. Román, X. He, A. Casado, J. de la Torre, V. Furio, J. Puente, T. Caldés, J. A. Vidart, Sara Lopez-Tarruella, E. Diaz-Rubio, C. M. Perou

Institutions: Universidad Complutense de Madrid, Hospital General Universitario Gregorio Marañón, Hospital Clínico San Carlos, University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center, Instituto de Salud Carlos III

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Cancer Institute

Awards: G108258030, SPORE in Breast Cancer

OpenAlex ID: W1984562552

FWCI: 2.741

Cites: 69

Cited by: 72

Related to: 10